Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank0
3Y CAGR-14.0%
5Y CAGR-27.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-14.0%/yr
vs -29.5%/yr prior
5Y CAGR
-27.4%/yr
Recent acceleration
Acceleration
+15.5pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.50M-78.6%
2024$7.02M+2.0%
2023$6.88M+192.0%
2022$2.36M-49.3%
2021$4.65M-37.3%
2020$7.42M+107.6%
2019$3.57M-62.5%
2018$9.54M-25.2%
2017$12.74M+87.8%
2016$6.79M-